Alexion Pharmaceuticals
ALXN
#629
Rank
โ‚น3.859 T
Marketcap
โ‚น17,462
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Alexion Pharmaceuticals (ALXN)

Revenue in 2021 (TTM): โ‚น462.63 Billion

According to Alexion Pharmaceuticals's latest financial reports the company's current revenue is โ‚น598.97 Billion. In 2020 the company made a revenue of โ‚น580.69 Billion an increase over the revenue in the year 2019 that were of โ‚น477.44 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alexion Pharmaceuticals from 2001 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚น462.63 B-20.33%
2020โ‚น580.69 B21.63%
2019โ‚น477.44 B20.82%
2018โ‚น395.16 B16.36%
2017โ‚น339.61 B15.17%
2016โ‚น294.88 B18.42%
2015โ‚น249.01 B16.51%
2014โ‚น213.72 B43.99%
2013โ‚น148.43 B36.79%
2012โ‚น108.51 B44.76%
2011โ‚น74.95 B44.82%
2010โ‚น51.75 B39.85%
2009โ‚น37.00 B49.29%
2008โ‚น24.79 B259.66%
2007โ‚น6.89 B4523.88%
2006โ‚น0.14 B13.14%
2005โ‚น0.13 B-70.12%
2004โ‚น0.44 B557.49%
2003โ‚น67.07 M-85.98%
2002โ‚น0.47 B-50.6%
2001โ‚น0.96 B